Drug repurposing screens reveal cell-type specific entry pathways and FDA approved drugs active against SARS-Cov-2 Dittmar et al.

Published: 16 March 2021| Version 2 | DOI: 10.17632/4m9sygn632.2
Contributor:
Sara Cherry

Description

Supplementary Data sets

Files

Institutions

University of Pennsylvania

Categories

High-Throughput Screening, Drug Screening

License